Search Ontology:
ChEBI

4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc

Term ID
CHEBI:149135
Synonyms
  • 4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-glucopyranose
  • beta-D-galacto-hexopyranosyl-(1->3)-[4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)]-2-acetamido-2-deoxy-beta-D-gluco-hexopyranose
  • Gal(b1-3)[4,6-deoxy-L-xylHex(a1-4)]b-GlcNAc
  • N-[(2R,3R,4R,5S,6R)-5-[(2S,3S,4R,6S)-3,4-dihydroxy-6-methyloxan-2-yl]oxy-2-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
Definition
An amino trisaccharide that is 2-acetamido-2-deoxy-β-D-glucopyranose in which the hydroxy groups at positions 3 and 4 have been converted to the corresponding β-D-galactopyranosyl and 4,6-dideoxy-α-L-xylo-hexopyranosyl derivatives, respectively.
References
  • glygen:G31060JS
  • glytoucan:G31060JS
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from 4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc
Phenotype where environments contain 4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc
Phenotype modified by environments containing 4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc
Phenotype affecting 4,6-dideoxy-alpha-L-xylo-hexopyranosyl-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc
Human Disease Model